Brief Summary
This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.
Protocol Interventions
Drug: RIC regimen, Drug: GVHD prophylaxis regimen
Brief Summary
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Protocol Interventions
Other: Cytology Specimen Collection Procedure, Other: Medical Chart Review
Brief Summary
The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.
Protocol Interventions
Drug: Treatment Plan 2: Strata 2, 3, or 4, Drug: GVHD Regimen A: UCB Recipients, Drug: GVHD Regimen B: BM Recipients